Caris Molecular Minute Podcast Series

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Igor Astsaturov, Co-director of the Pancreatic Institute at Fox Chase Cancer Center and Chairman of the Caris Molecular Tumor Board. Together they discuss molecular tumor boards and how they are utilized at Caris and other academic sites.

For more information, please visit: www.CarisLifeSciences.com

Interview with Dr. Igor Astsaturov: Molecular Tumor Boards

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Ben Weinberg, Associate Professor of Medicine at Georgetown University, to discuss the latest findings and top abstracts presented at this year's ASCO GI meeting.

For more information, please visit: www.CarisLifeSciences.com

Interview with Dr. Ben Weinberg: Top Abstracts from ASCO GI 2022

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Tian Zhang, Associate Professor at UT Southwestern Medical Center, to discuss the latest findings and top abstracts presented at this year's ASCO GU meeting.

For more information, please visit: www.CarisLifeSciences.com

Interview with Dr. Tian Zhang: Top Abstracts from ASCO GU 2022

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Patricia Pittman, oncologic pathologist and neuropathologist at Caris Life Sciences, to discuss the latest in neuropathology.

For more information, please visit: www.CarisLifeSciences.com

Interview with Dr. Patricia Pittman: Neuropathology

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Jamie Holloway, Area Vice President, Molecular Science Liaison at Caris Life Sciences. Together, they take a closer look at the Caris Report and explain how its results aid oncologists in personalizing cancer therapies for their patients.

For more information, please visit: www.CarisLifeSciences.com

Interview with Dr. Jamie Holloway: Interpreting the Caris Report

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Jimmy Hwang, Chief, GI Medical Oncologist at the Levine Cancer Institute. Dr. Hwang recently contributed to a JCO publication titled, “Somatic Genomic Testing in Patients with Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion.” Together, Dr. Nabhan and Dr. Hwang discuss the recommendations made in this article and the impact genomic testing can have on patient outcomes.

To access this article, please visit: https://ascopubs.org/doi/full/10.1200/JCO.21.02767

For more information, please visit: www.CarisLifeSciences.com

Interview with Dr. Jimmy Hwang: Author to ASCO Provisional Opinion on Genomic Testing

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Salma Jabbour, Clinical Chief, Radiation Oncology and Vice Chair of Clinical Research & Faculty Development at RWJUH/Rutgers Cancer Institute. Together they discuss a plenary presentation that was given at ASCO 2023 on rectal cancer titled, the PROSPECT (Preoperative Radiation or Selective Preoperative Radiation and Evaluation before Chemotherapy and TME) trial.

The PROSPECT trial attempts to challenge the current treatment paradigm by individualizing treatment through the use of radiotherapy selectively rather than reflexively. This is a randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total mesorectal excision (TME) for the treatment of locally advanced rectal cancer (LARC).

For more information, please visit: www.CarisLifeSciences.com

Interview with Dr. Salma Jabbour:  An In-depth Look at the PROSPECT Trial

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Soma Sengupta, the Harold C. Schott Endowed Brain Tumor Molecular Therapeutics Chair and Associate Professor of Clinical at the University of Cincinnati. Together they explore the myriad of challenges in accurately diagnosing this aggressive brain tumor while examining the latest advancements in frontline treatment strategies.

For more information, please visit: www.CarisLifeSciences.com

Interview with Dr. Soma Sengupta: Advances in Glioblastoma Multiforme (GBM)

Caris Precision Oncology Alliance Chairman, Dr. Chadi Nabhan, sits down with Dr. Tina Bhatnagar, Associate Professor, Director of Hematology and Medical Oncology at West Virginia University. Together they discuss disparities research, the types of methodologies used and what can be done to mitigate the disparities seen in practice.

For more information, please visit: www.CarisLifeSciences.com

Interview with Dr. Tina Bhatnagar: What's Next in Disparities Research?

Caris Precision Oncology Alliance Chairman, Dr. Chadi Nabhan, sits down with Dr. Charu Aggarwal, the Leslye M. Heisler Associate Professor for Lung Cancer Excellence at UPENN, and Dr. Balazs Halmos, Director, Thoracic Oncology at Montefiore. Together they discuss adjuvant and neoadjuvant therapy for resected non-small cell lung cancer (NSCLC). Topics discussed include current treatment options, how treatment decisions are made and when treatment should be given.

For more information, please visit: www.CarisLifeSciences.com

Interview with Drs. Charu Aggarwal & Balazs Halmos: Adjuvant & Neoadjuvant Therapy for Lung Cancer

Caris Precision Oncology Alliance Chairman, Dr. Chadi Nabhan, sits down with Dr. George Sledge, Executive Vice President and Chief Medical Officer at Caris Life Sciences. Together they delve into his inspiring career as a prominent breast cancer specialist, his passion for this field, and his vision for the future of breast cancer care.

For more information, please visit: www.CarisLifeSciences.com

Interview with Dr. George Sledge: A Breast Cancer Specialist's Journey

Caris Precision Oncology Alliance Chairman, Dr. Chadi Nabhan, sits down with Jeanine Cervoni, Senior Director, Commercial Education at Caris Life Sciences in this latest episode of the Caris Molecular Minute podcast series. Join them in this empowering podcast as she shares the strength, resilience and hope that powered her through her personal breast cancer journey.

For more information, please visit: www.CarisLifeSciences.com

Interview with Jeanine Cervoni: Hope, Resilience and Healing

Caris Precision Oncology Alliance Chairman, Dr. Chadi Nabhan, sits down for an engaging podcast interview with Dr. David Braxton, Chief of Service for Molecular Pathology at Hoag Hospital in Newport Beach, California. Explore Dr. Braxton's remarkable career as a molecular pathologist and delve into the pivotal role molecular pathologists play in precision oncology, while examining the progressive integration of artificial intelligence within molecular pathology.

For more information, please visit: www.CarisLifeSciences.com

Interview with Dr. David Braxton: Molecular Pathology and Precision Medicine

Join Caris Precision Oncology Alliance Chairman, Dr. Chadi Nabhan, and Dr. Salma Jabbour, Clinical Chief, Radiation Oncology and Vice Chair of Clinical Research & Faculty Development at RWJUH/Rutgers Cancer Institute, as they delve into the depths of radiation therapy in cancer care. Together they unravel the intricacies of this vital treatment option, covering its mechanisms, innovations, and the pivotal role it plays in the journey towards effective oncological treatment for patients.

For more information, please visit: www.CarisLifeSciences.com

Interview with Dr. Salma Jabbour: Radiation Therapy Simplified

Join Dr. Chadi Nabhan, Chairman of the Caris Precision Oncology Alliance, in a captivating podcast conversation with special guest Dr. Emil Lou, Associate Professor of Medicine at the University of Minnesota. Delve into the intricate connections between pathogens and cancer, exploring both research breakthroughs and the clinical implications. Gain valuable insights into the current landscape and discover what the future holds for this dynamic intersection of science and medicine.

For more information, please visit: www.CarisLifeSciences.com

Interview with Dr. Emil Lou: Pathogens and Cancer Associations

Caris Precision Oncology Alliance Chairman, Dr. Chadi Nabhan, sits down for an engaging podcast interview with Dr. Ari VanderWalde, Global Head of Clinical Trials at Caris Life Sciences. Join them as they delve into the world of clinical trials, exploring the intricacies of clinical research, providing valuable insights into Caris' contributions, and the accessibility of these transformative opportunities.

For more information, please visit: www.CarisLifeSciences.com

Interview with Dr. Igor Astsaturov: Molecular Tumor Boards

Caris Molecular Minute Podcast Series

Related tracks